Uniplant
Product Details
Duration: One year
Dose: 55 mg
Active Pharmaceutical Ingredient (API):
Inactive material: silastic
Status Details
Developer: , ,
Status Details: - Current market status unclear, though previously available in Latin America.
- Current market status unclear, though previously available in Latin America.
Additional Information
References: Coutinho EM, de Souza JC, Athayde C, et al. Multicenter clinical trial on the efficacy and acceptability of a single contraceptive implant of nomegestrol acetate, Uniplant. Contraception. 1996;53:121–125.
Coutinho EM, de Souza JC, Athayde C, et al. Multicenter clinical trial on the efficacy and acceptability of a single contraceptive implant of nomegestrol acetate, Uniplant. Contraception. 1996;53:121–125.
Footnotes: - Theramex was acquired by Teva in 2010.
- Theramex was acquired by Teva in 2010.